On Dec. 15, the industry’s most popular drug benefits conference returned in a virtual format, highlighting the trends and opportunities for Canadian benefits plan sponsors to consider.

Here’s what you missed:

Using proactive drug plan design to ensure future sustainability

Ensuring plan sponsors get value for money from their drug plans

Patient support program insights can inform payer programs

Incorporating diversity, equity and inclusion in drug plan design

How the evolution of pharmacy can impact benefits plan costs

The impact of mental health on drug plan sustainability

An update on Canada’s national strategy for drugs for rare diseases